3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Promyelocytic, Acute
1
Interventions
pembrolizumab
17
Carboplatin
13
Paclitaxel
12
Cisplatin
12
Radiation
10
Doxorubicin
10
Cyclophosphamide
9
Radiotherapy
8
Vincristine
7
Nivolumab
7
Metformin
7
Etoposide
7
Cytarabine
7
Radiotherapy, Intensity-Modulated
6
Magnetic Resonance Spectroscopy
6
Leucovorin
6
Injections
6
Fluorouracil
6
tislelizumab
5
Prednisone
5
Pemetrexed
5
Methotrexate
5
Ipilimumab
5
Cetuximab
5
Bevacizumab
5
fludarabine
4
durvalumab
4
atezolizumab
4
Specimen Handling
4
Radiotherapy, Conformal
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Tretinoin
×
30 days
×
Clear all
NCT02688140
2026-05-29
TUD-APOLLO-064
Technische Universität Dresden
Phase 3
Completed
133 enrolled